Ann‐Christin von Brünneck

Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas

Arne Warth, Albrecht Stenzinger, Ann‐Christin von Brünneck et al. · European Respiratory Journal · 2012 · 116 citations · Full text

Medicine, Oncology, Pathology +16

Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis

Franziska Scheibe, Lennard Ostendorf, S. Momsen Reincke et al. · Journal of Neurology · 2019 · 69 citations

Medicine, Pharmacology, Pharmacotherapy +13

B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceased

Jana Ihlow, Edward Michaelis, Selina Greuel et al. · International Journal of Infectious Diseases · 2021 · 22 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Differential expression of secretoglobins in normal ovary and in ovarian carcinoma – Overexpression of mammaglobin-1 is linked to tumor progression

Katharina Fischer, Ann‐Christin von Brünneck, Daniela Hornung et al. · Archives of Biochemistry and Biophysics · 2014 · 14 citations

Medicine, Gynecology, Oncology +13

Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma

Sofya Marchenko, Iris Piwonski, Inga Hoffmann et al. · Journal of Cancer Research and Clinical Oncology · 2022 · 13 citations · Full text

Life Sciences, Immunology, Oncology +17